- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
Vesicoureteral Reflux (VUR) |
8 |
in Children |
8.1Introduction
•Normally urine travels antegrade in one direction from the kidneys to the bladder via the ureters to the urinary bladder.
•Backward or retrograde flow of urine from the urinary bladder to the ureters or kidneys is prevented by a one way valve at the ureterovesical junction.
•The valve is formed by the oblique entrance of the distal ureter through the wall of the bladder. This creates a tunnel of about 1–2 cm into the wall of the urinary bladder.
•This tunnel is compressed as the bladder fills preventing backflow of urine.
•Vesicoureteral reflux (VUR) is a retrograde flow of urine from the bladder into the ureters/ kidneys (Fig. 8.1).
•VUR occurs if the submucosal ureteric tunnel is short making the valve defective.
•VUR is one of the common conditions in infants and children.
•It has been estimated that 10 % of the population have some degree of VUR.
•VUR is more common among younger children because of the relative shortness of the submucosal ureteric tunnel.
•This susceptibility decreases as the child grows. This is as a result of growth and increase in the length of the ureteric tunnel.
•It has been estimated that in children under the age of 1 year with a urinary tract infection, 70 % of them will have VUR.
•This frequency decreases to 15 % by the age of 12 years.
•VUR is more commonly diagnosed in males antenatally, but in later life there is a definite female preponderance with 85 % of VUR cases being diagnosed in females.
•Overall prevalence of vesicoureteral reflux is unknown because many children are asymptomatic.
•A frequency of 1–2 % of VUR was reported among healthy children.
Fig. 8.1 A micturating cystourethrogram showing sever bilateral vesicoureteral reflux
© Springer International Publishing Switzerland 2017 |
237 |
A.H. Al-Salem, An Illustrated Guide to Pediatric Urology, DOI 10.1007/978-3-319-44182-5_8 |
|
238 |
|
8 Vesicoureteral Reflux (VUR) in Children |
||||
|
|
|||||
• The prevalence of VUR is higher among chil- |
• It was estimated that among patients who pre- |
|||||
dren with UTIs ranging from 15 to 70 %, |
|
sented with UTI: |
|
|
|
|
depending on age. |
|
– The prevalence of VUR was 70 % in |
||||
• Approximately one third of patients diag- |
|
patients younger than 1 year |
|
|
||
nosed prenatally with hydronephrosis on |
|
– The prevalence of VUR was 25 % in |
||||
ultrasonography, were found postnatally to |
|
patients aged 4 years |
|
|
|
|
have VUR. |
|
– The prevalence of VUR was 15 % in those |
||||
• The incidence of reflux clearly is influenced |
|
aged 12 years |
|
|
|
|
by genetic factors, although the specific modes |
|
– The prevalence of VUR was 5.2 % in adult |
||||
of inheritance is not defined. |
|
patients. |
|
|
|
|
– Siblings of children with vesicoureteral |
• VUR is more prevalent in male newborns, but |
|||||
reflux have a 25–33 % risk of also having |
|
VUR seems to be five to six times more com- |
||||
VUR. |
|
mon in females older than 1 year than in |
||||
– Offspring of parents with VUR have a 66 % |
|
males. |
|
|
|
|
risk of also having VUR. |
• The incidence |
decreases |
as |
patient |
age |
|
– This is higher in female offspring than |
|
increases. |
|
|
|
|
male offspring. |
• Approximately |
three-quarters |
of children |
|||
• There are two distinct presentations of VUR: |
|
being treated for reflux are girls. |
|
|
||
– Hydronephrosis, often prenatally identified |
• |
The diagnosis of VUR depends on clinical |
||||
using ultrasonography. |
|
suspicion and radiological investigations. The |
||||
– Clinical urinary tract infection. |
|
indications for radiological evaluation after |
||||
• VUR can occur at any age but the average age |
|
the first attack of urinary tract infection |
||||
at diagnosis of VUR is 2–3 years. |
|
include: |
|
|
|
|
• It was suggested that early diagnosis of chil- |
|
– All children younger than 5 years. |
|
|||
dren with VUR may prevent episodes of UTI |
|
– Children of any age with febrile urinary |
||||
and renal scarring. |
|
tract infection. |
|
|
|
|
• Others feel that screening asymptomatic chil- |
|
– Boys of any age with urinary tract |
||||
dren will result in overtreatment of clinically |
|
infection. |
|
|
|
|
insignificant VUR. |
• In patients with VUR, there is a close correla- |
|||||
• VUR is more common in white children than |
|
tion between the frequency of urinary tract |
||||
in those of other races. |
|
infection and the severity of VUR |
||||
• VUR is less common in black children. |
|
nephropathy. |
|
|
|
|
• VUR is ten times as common in white chil- |
• |
VUR nephropathy is considered the most |
||||
dren as in black children. |
|
common cause of childhood hypertension |
||||
• UTIs are known to be more common in girls |
|
which is caused by increased renin secretion |
||||
than boys. |
|
as a result of renal scarring (Figs. 8.2, 8.3, 8.4, |
||||
• Among all children with UTIs, boys are more |
|
and 8.5). |
|
|
|
|
likely to have vesicoureteral reflux than girls |
• |
The most devastating complication of VUR |
||||
(29 % of males vs 14 % of females). |
|
nephropathy is renal failure. |
|
|
|
|
• Boys also tend to have higher grades of vesi- |
• Vesicoureteral |
reflux can |
be |
primary |
or |
|
coureteral reflux diagnosed at younger ages. |
|
secondary. |
|
|
|
|
• Vesicoureteral reflux is more likely to sponta- |
|
– Primary vesicoureteral reflux results |
||||
neously resolve in boys when compared to |
|
from a defect in the “flap valve” effect |
||||
girls. |
|
that normally prevents urine from flow- |
||||
• VUR is more common among infants and pro- |
|
ing backward from the bladder into the |
||||
gressively resolves in a substantial proportion |
|
ureters. |
|
|
|
|
of children. |
|
– Secondary vesicoureteral reflux results |
||||
• The prevalence of VUR decreases as children |
|
from defective micturation secondary to |
||||
age. |
|
obstruction in the urethra such as posterior |
8.1 Introduction |
239 |
|
|
Figs. 8.2 and 8.3 Abdominal ultrasound showing atrophic left kidney secondary to VUR
Hydronephrosis Diagnosed Prenatally
Figs. 8.4 and 8.5 Clinical photographs showing hydroureters and dysplastic atrophic kidneys secondary to VUR
urethral valve or stricture or neurogenic bladder.
•More than 50 % of boys with posterior urethral valves have VUR. This can be unilateral or bilateral (Figs. 8.6 and 8.7).
•Dysfunctional voiding, with its inherent increase in intravesical pressure also results in VUR, even in otherwise healthy children.
•The incidence of VUR is much higher in children with febrile UTIs (i.e., 30–70 %).
•The incidence of prenatally diagnosed hydronephrosis caused by VUR ranges from 17 % to 37 % in the pediatric population.
•Approximately 20–30 % of children with VUR present with renal lesions (Fig. 8.8).
•The incidence of VUR in children and young adults with end-stage renal failure that necessitates dialysis or transplantation is about 6 %.
•VUR is the fifth-most-common cause of endstage renal failure in children.
•50 % are transient and resolve spontaneously.
•15 % have hydronephrosis that persists but is not associated with urinary tract obstruction (non-refluxing, nonobstructive hydronephrosis).
•35 % have a definite pathological cause for hydronephrosis. These include:
–Pelvi-ureteric junction obstruction (11 %)
–Vesicoureteral reflux (9 %)
–Mega ureter (4 %)
–Multicystic dysplastic kidney (2 %)
–Ureterocele (2 %)
–Posterior urethral valves (1 %)
•Vesicoureteral reflux (VUR) may be associated with:
–Urinary tract infection (UTI)
–Hydronephrosis
–Abnormal kidney development (renal dysplasia)
–Increased risk for pyelonephritis, hypertension, and progressive renal failure.
•VUR with concomitant UTI if not recognized and treated may lead to long-term effects on renal function and overall patient health.
•The severity of VUR greatly varies and thus may affect patients differently. Some individuals have a genetic predisposition to renal injury.
•Early diagnosis and vigilant monitoring of VUR are the cornerstones of management.
240 |
8 Vesicoureteral Reflux (VUR) in Children |
|
|
Figs. 8.6 and 8.7 Micturating cystourethrograms showing posterior urethral valve and VUR. Note the dilated posterior urethra
Fig. 8.8 A clinical intraoperative photograph showing a duplex system with hydroureter secondary to VUR and dysplastic kidney
8.2Pathophysiology
•Anatomically, the ureter enters the urinary bladder through a hiatus in the detrusor muscle.
•The ureter is composed of three muscle layers: inner longitudinal, middle circular, and outer longitudinal.
•The outer longitudinal layer is enveloped by ureteral adventitia.
•The inner longitudinal layer of smooth muscle passes through the ureteral hiatus, continues distally beyond the ureteral orifice into the trigone, and intertwines with the smooth muscle fibers of the contralateral ureter, forming the Bell muscle of the trigone and posterior urethra.
•The middle circular muscle fibers, outer longitudinal muscle fibers, and periureteral adventitia merge with the bladder wall in the upper part of the ureteral hiatus to form the Waldeyer sheath.
•This sheath attaches the extravesical portion of the ureter to the ureteral hiatus.
•The normal valve mechanism of the ureterovesical junction includes:
– Oblique insertion of the intramural ureter
8.2 Pathophysiology |
241 |
|
|
–Adequate length of the intramural portion of the ureter
–Strong detrusor support.
•The distal ureter then passes obliquely through a submucosal tunnel before opening into the bladder lumen via the ureteral orifice.
•This creates a tunnel of about 1–2 cm long into the wall of the urinary bladder.
•This tunnel is compressed as the bladder fills and the intravesical pressure increases preventing backflow of urine from the urinary bladder to the upper urinary tract.
•The length of this submucosal tunnel and the muscular coat is important in creating a one-way valve preventing backflow of urine.
•If the length of the submucosal tunnel is short or if the muscular backing is inadequate, the
one-way valve mechanism becomes incompetent, resulting in reflux.
•It was found that the ratio of tunnel length to ureteral diameter is important in the one-way mechanism.
•A ratio of at least 5:1 is important to ensure a competent one-way valve to prevent reflux.
•An abnormal short intramural tunnel results in a malfunctioning flap-valve mechanism and urine tends to reflux up the ureter and into the collecting system (VUR).
•It was estimated that refluxing ureters have an intramural tunnel length–to–ureteral diameter ratio of 1.4:1.
•When this protective mechanism fails, VUR occurs.
•VUR will lead to ascending infection and pyelonephritis which are the essential causes of reflux nephropathy.
Vesicoureteral reflux
Urinary tract infection and Pyelonephritis
Renal scarring
Chronic kidney disease
|
|
|
|
|
|
End stage |
Hypertension |
|
Decreased renal |
|
Proteinuria |
|
|
|
function |
|
|
|
renal disease |
|
|
|
|
|
|
||
|
|
|
|
|
|
(ESRD) |
|
|
|
|
|
||
|
|
|
|
|
|
|
242 |
8 Vesicoureteral Reflux (VUR) in Children |
|
|
•A close correlation was established between the frequency of UTI and severity of reflux nephropathy in patients with vesicoureteral reflux.
•Renal scarring may result from a single episode of pyelonephritis, especially in very young patients.
•Most renal scarring tends to occur at the renal poles, where the anatomy of the renal papillae permits backflow of urine into the collecting ducts.
•This phenomenon is referred to as intrarenal reflux and gives pathogenic bacteria access to the renal tubules.
•The human kidney contains two types of renal papillae:
–Simple (convex) papilla
–Compound (concave) papilla
•Compound papillae are commonly seen at the polar regions of the kidney, whereas simple papillae are located at nonpolar regions of the kidney.
•Approximately 66 % of human papillae are simple (convex) and 33 % are compound (concave).
•Intrarenal reflux or retrograde movement of urine from the renal pelvis into the renal parenchyma is a function of intrarenal papilla.
•Simple papillae possess oblique, slit like, ductal orifices that close upon increased intrarenal pressure and do not allow intrarenal reflux.
•Compound papillae possess gaping orifices that are perpendicular to the papillary surface that remain open upon increased intrarenal pressure allowing free intrarenal reflux.
•Renal scars are often present at initial diagnosis of VUR and usually develop during the first years of life.
•Persistent intrarenal reflux causes renal scarring and eventual reflux nephropathy.
•Reflux nephropathy leads to:
–Impaired renal function
–Hypertension
–Proteinuria
–End stage renal disease
•These effects depend on the type of urine.
•Two types of urine may reflux and enter the renal papillae: infected urine or sterile urine.
•Intrarenal reflux of infected urine is primarily responsible for the renal damage.
•The presence of bacterial endotoxins (lipopolysaccharides) activates the host’s immune
response and a release of oxygen free radicals. The release of oxygen free radicals and proteolytic enzymes results in fibrosis and scarring of the affected renal parenchyma during the healing phase.
•This initial scar formation at the infected polar region distorts the neighboring papillae and converts simple papillae into compound papillae.
•Compound papillae, in turn, perpetuate further intrarenal reflux which further increases renal scarring.
•Compound papillae are most commonly found at the renal poles, where renal scarring is most commonly observed.
•These focal areas of renal scars can be detected by Renal scan (DMSA).
•Diffuse lesions on renal scan are believed to be due to renal dysplasia, which results from abnormal kidney development.
•It is observed in patients who have higher grades of reflux (IV and V) and who have never had any evidence of UTI or pyelonephritis.
•Intrarenal reflux of sterile urine (under normal intrapelvic pressures) has not been shown to produce clinically significant renal scars.
•Treatment with long-term low-dose antibiotic prophylaxis to maintain sterile urine appears to inhibit renal scarring in children with uncomplicated VUR.
•Thus, renal scars appear to develop only in the presence of intrarenal reflux of infected urine.
•One exception to this is intrarenal reflux of sterile urine in the presence of abnormally high intravesical pressures.
•Abnormally high intravesical pressure is seen in:
–Bladder outlet obstruction (functional or anatomical)
–Nonneurogenic neurogenic bladder, or Hinman syndrome
–Gastrointestinal dysfunction including chronic constipation
–Children with overactive bladder (e.g. detrusor hyperreflexia, detrusor instability)
•Renal lesions are associated with higher grades of reflux.
•Renal units with low-grade reflux may grow normally, but high grades of reflux are associated with renal growth retardation.
8.3 Classification of VUR |
243 |
|
|
•Pyelonephritic scarring may, over time, cause serious hypertension due to activation of the renin-angiotensin system.
•Scarring related to VUR is one of the most common causes of childhood hypertension.
•It was estimated that hypertension develops in 10 % of children with unilateral scars and in 18.5 % with bilateral scars.
•Approximately 4 % of children with VUR progress to end-stage renal failure.
•This defect causes inadequacy of the valvular mechanism and failure of its function as a one-way valve leading to backflow of urine from the urinary bladder to the ureters and kidneys.
•This defect can be unilateral or bilateral (Fig. 8.11)
8.3Classification of VUR
•VUR is classified into two types:
–Primary VUR:
•This is the most common type of VUR (Figs. 8.9 and 8.10).
•It is caused by a defect in the development of the valve-like effect at the uretrovesical junction with insufficient submucosal ureteric length relative to its diameter.
•This type is usually detected antenataly or shortly after birth.
•Primary reflux is vesicoureteral reflux in an otherwise normally functioning lower urinary tract.
•This is precipitated by a congenital defect.
•Lack of longitudinal muscle of the intravesical ureter result in anomaly of the ureterovesicular junction (UVJ).
Fig. 8.11 A micturating cystourethrogram showing bilateral VUR
Figs. 8.9 and 8.10 Micturating cystourethrogram showing severe VUR. Note the dilated tortous ureters
244 |
8 Vesicoureteral Reflux (VUR) in Children |
|
|
Figs. 8.12 and 8.13 Micturating cystourethrograms showing posterior urethral valve and associated secondary VUR. Note the dilated posterior urethra and the diverticulae from the urinary bladder
–Secondary VUR:
•Secondary reflux is vesicoureteral reflux that is associated with or caused by an obstructed or poorly functioning lower urinary tract.
•In this category the valvular mechanism is intact and healthy to start with but becomes overwhelmed by raised intravesicular pressures associated with obstruction.
•This leads to distortion of the ureterovesical junction and failure of its function as a one-way valve.
•Secondary VUR can be further divided into anatomical and functional groups.
•This is seen in those with posterior urethral valves (anatomical) or a neurogenic bladder (functional).
•The main causes of secondary VUR are:
–Posterior urethral valves (Figs. 8.12, 8.13, 8.14, and 8.15)
–Neurogenic bladder
–Urethral stricture (Figs. 8.16 and 8.17)
–Meatal stenosis
•VUR is also classified into five grades:
–Voiding cystourethrography (VCUG) is the criterion standard in diagnosis of VUR, providing precise anatomic detail and allows grading of the reflux.
8.3 Classification of VUR |
245 |
|
|
Figs. 8.14 and 8.15 Micturating cystourethrograms showing posterior urethral valve without VUR
Figs. 8.16 and 8.17 Micturating cystourethrogram showing urethral
stricture secondary to hypospadias repair and secondary mild VUR
246 |
8 Vesicoureteral Reflux (VUR) in Children |
|
|
Figs. 8.18 and 8.19 Diagrammatic representation of grade I VUR. The blue color represents urine in the ureter
–The International Classification System for VUR is based on the radiographic appearance of the ureter, renal pelvis and calyces on a voiding cystogram.
–It is important to note that the presence of a severe reflux on one side may hide a milder degree of reflux on the other side in those with bilateral reflux.
–In these cases reflux on the milder side may appear postoperatively following treatment of the more severely affected side.
–This is one of the causes of appearance of reflux on the contralateral side following successful treatment of the severely affected side.
–The International Classification System for VUR is as follows:
•Grade I – Reflux into nondilated ureter (Figs. 8.18, 8.19, and 8.20)
•Grade II – Reflux into renal pelvis and calyces without dilation (Figs. 8.21 and 8.22)
Fig. 8.20 A micturating cystourethrogram showing grade I VUR
•Grade III – Reflux with mild to moderate dilation and minimal blunting of fornices (Figs. 8.23, 8.24, and 8.25)
•Grade IV – Reflux with moderate ureteral tortuosity and dilation of pelvis and calyces (Figs. 8.26, 8.27, and 8.28)